Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Ronen Tivony/Echoes Wire/Barcroft Media via Getty Images

The Department of Justice's lawsuit against CVS Health, alleging the falsification of old prescriptions and creation of new improper refills, wasn't the only major legal battle in health care world yesterday.

Driving the news: The Federal Trade Commission is suing to block Illumina's $1.2 billion takeover of PacBio, which competes with Illumina for DNA sequencing that helps find disease patterns.

  • "When a monopolist buys a potential rival, it can harm competition. These deals help monopolists maintain power," FTC Bureau of Competition Deputy Director Gail Levine said in a release.

Michigan is the first state to sue opioid distributors — specifically AmerisourceBergen, Cardinal Health, McKesson and Walgreens — as drug dealers.

  • "Wall Street underestimates the magnitude and depth of the opioid situation and the extent to which plaintiffs will seek restitution," stock analysts with Robert W. Baird & Co. wrote on the news.

A new class-action lawsuit, filed by a physician in Illinois, alleges TeamHealth violated federal communications law by texting recruitment pitches to physicians without their consent.

The bottom line: The health care industry takes up a lot space in the courts, given the nature of medical treatments and the ties to taxpayer funding. And all of this is happening while we await the imminent decision on the latest ACA case.

Go deeper: A health care settlement parade

Go deeper

2 hours ago - Health

Beware a Thanksgiving mirage

Illustration: Sarah Grillo/Axios

Don't be surprised if COVID metrics plunge over the next few days, only to spike next week.

Why it matters: The COVID Tracking Project warns of a "double-weekend pattern" on Thanksgiving — where the usual weekend backlog of data is tacked on to a holiday.

Trump pardons Michael Flynn

President Trump with Michael Flynn in 2016. Photo: David Hume Kennerly/Getty Images

President Trump on Wednesday pardoned his former national security adviser Michael Flynn, who pleaded guilty in the Mueller investigation to lying to FBI agents about his conversations with a former Russian ambassador.

Why it matters: It is the first of multiple pardons expected in the coming weeks, as Axios scooped Tuesday night.